Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05220254 · ClinicalTrials.gov registry record · NA

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

A NA study of Smoking Cessation and MindCotine Virtual Reality Mindful Exposure Therapy, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05220254 is a NA study of Smoking Cessation and MindCotine Virtual Reality Mindful Exposure Therapy that has completed, run by Stanford University. The registered enrollment target is 20 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05220254, a NA study of Smoking Cessation and MindCotine Virtual Reality Mindful Exposure Therapy, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients

Interventions

  • BEHAVIORAL MindCotine's VR app

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-10-18
Est. Completion 2022-10-27
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05220254

The ClinicalTrials.gov registry entry for NCT05220254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which MindCotine's VR app is the first listed.

NCT05220254 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05220254 about?

NCT05220254 is a clinical study titled "Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation". This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients

What is the current status of trial NCT05220254?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-18. Estimated completion is 2022-10-27.

What conditions does trial NCT05220254 study?

This clinical trial studies the following conditions: Smoking Cessation, MindCotine Virtual Reality Mindful Exposure Therapy.

What interventions are being tested in trial NCT05220254?

The interventions under investigation include: MindCotine's VR app (BEHAVIORAL).

Who is sponsoring clinical trial NCT05220254?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05220254 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.